Select a Community
Are you sure you want to trigger topic in your Anconeus AI algorithm?
You are done for today with this topic.
Would you like to start learning session with this topic items scheduled for future?
Atropine
38%
6/16
Diphenhydramine
6%
1/16
Naloxone
12%
2/16
Physostigmine
0%
0/16
Transcutaneous pacing
Select Answer to see Preferred Response
This patient is presenting with diarrhea, urinary incontinence, excessive tearing, and increased salivation which is concerning for a cholinergic toxidrome which is most likely a result of organophosphate poisoning. Treatment includes administration of atropine. Organophosphates are acetylcholinesterase inhibitors which lead to decreased breakdown of acetylcholine (resulting in increased levels of acetylcholine). Excess acetylcholine is characterized by symptoms of diarrhea, urination, miosis, bronchospasm, bradycardia, emesis, lacrimation, lethargy, and salivation (DUMBBELLS is a common mnemonic). Atropine is the treatment of choice due to its anticholinergic activity that blocks the peripheral action of excess acetylcholine. It should be administered until respiratory symptoms (bronchorrhea and increased respiratory secretions) resolve. Additionally, pralidoxime or 2-PAM is also given to reactivate acetycholinesterase. Incorrect Answers: Answer 2: Diphenhydramine is an antihistamine with anticholinergic properties which in overdose, can cause an anticholinergic toxidrome (hot/dry skin, confusion, urinary retention, and constipation). Despite its anticholinergic properties, it is not the antidote of choice for a cholinergic toxidrome. Answer 3: Naloxone is an opioid receptor antagonist and would be given in opioid overdose which presents with miosis, decreased bowel sounds, and bradypnea. Answer 4: Physostigmine is an acetylcholinesterase inhibitor. It is commonly used as a treatment for myasthenia gravis to increase cholinergic transmission. Administration of this agent would exacerbate the patient's symptoms and further increase acetylcholine levels. Answer 5: Transcutaneous pacing could be given in a patient with heart block who is bradycardic and/or not perfusing well. It is generally not indicated first line in the management of a cholinergic toxidrome and would not address the other symptoms this patient is having other than his bradycardia. Bullet Summary: Atropine is the treatment of choice for a cholinergic toxidrome.
4.4
(15)
Please Login to add comment